Search Videos and More

Showing 1 - 12 of 183 results

Previous| 1 | 2 | 3 ...16 |Next


Dana-Farber Researcher Awarded Victoria Mock New Investigator Award News

Dana-Farber Researcher Awarded Victoria Mock New Investigator Award

Rachel Pozzar, PhD, RN, a nurse scientist in the Phyllis F. Cantor Center for Research in Nursing and Patient Care Services at Dana-Farber Cancer Institute and an instructor in medicine at Harvard Medical School, has been awarded the 2023 Oncology Nursing Society’s (ONS) Victoria Mock New Investigator Award.
Dana-Farber Research Publication 2.1.2022 News

Dana-Farber Research Publication 2.1.2022

Dana-Farber Research Publication 02.01.2023 News

Dana-Farber Research Publication 02.01.2023

This twice-monthly newsletter highlights the research endeavors at Dana-Farber Cancer Institute, noting recently published papers available from PubMed where Dana-Farber faculty are listed as first or senior authors.
Study Links Key Activating Enzymes to Specific Sites on Proteins in Cells News

Study Links Key Activating Enzymes to Specific Sites on Proteins in Cells

Thousands of proteins in a human cell are regulated by phosphorylation -- the addition of small chemical groups to the proteins’ amino acids by enzymes called protein kinases.
Dana-Farber Research Publication 1.15.2022 News

Dana-Farber Research Publication 1.15.2022

This twice-monthly newsletter highlights the research endeavors at Dana-Farber Cancer Institute, noting recently published papers available from PubMed where Dana-Farber faculty are listed as first or senior authors.
Dana-Farber Research Publication 1.1.2022 News

Dana-Farber Research Publication 1.1.2022

This twice-monthly newsletter highlights the research endeavors at Dana-Farber Cancer Institute, noting recently published papers available from PubMed where Dana-Farber faculty are listed as first or senior authors.
Dana-Farber Research Publication 01.15.2023 News

Dana-Farber Research Publication 01.15.2023

This twice-monthly newsletter highlights the research endeavors at Dana-Farber Cancer Institute, noting recently published papers available from PubMed where Dana-Farber faculty are listed as first or senior authors.
Molecular Tumor Board Provides Useful Assist in Cancer Precision Medicine News

Molecular Tumor Board Provides Useful Assist in Cancer Precision Medicine

The field of precision cancer medicine has become so complex that even experienced oncologists can find it challenging to decipher the results of molecular tests of tumor tissue and navigate treatment options for patients. At Dana-Farber Cancer Institute, a multi-disciplinary team has been assisting gastrointestinal cancer physicians – reviewing test results and offering timely recommendations on treatment options.
Study Finds Racial Inequities in Access to Opioids Among Older Patients With Cancer Near End of Life News

Study Finds Racial Inequities in Access to Opioids Among Older Patients With Cancer Near End of Life

Older Black and Hispanic patients with advanced cancer are less likely to receive opioid medications for pain relief in the last weeks of life than White patients, a new study led by Dana-Farber Cancer Institute investigators found.
New Receptor “Decoy” Drug Neutralizes COVID-19 Virus and Its Variants News

New Receptor “Decoy” Drug Neutralizes COVID-19 Virus and Its Variants

Scientists at Dana-Farber Cancer Institute have developed a drug that potently neutralizes SARS-CoV-2, the COVID-19 coronavirus, and is equally effective against the Omicron variant and every other tested variant.
Three-Drug Combination Therapy Effective in Patients with High-Risk CLL, Trial Shows News

Three-Drug Combination Therapy Effective in Patients with High-Risk CLL, Trial Shows

A three-drug combination that sent chronic lymphocytic leukemia (CLL) into deep remissions in a broad group of patients in a clinical trial is highly effective in patients with high-risk forms of the disease, a new, phase 2 clinical trial led by Dana-Farber Cancer Institute investigators indicates.
Research With a Worldwide Reach News

Research With a Worldwide Reach

Around the world, Dana-Farber's Susan F. Smith Center for Women's Cancers is known not just for its exceptional patient care, but also for the driving force its physician-scientists play in developing new paradigms of cancer treatment through pioneering research and clinical trials.

Showing 1 - 12 of 183 results

Previous| 1 | 2 | 3 ...16 |Next